Robert Clarke

Northern Irish oncologist

DBpedia resource is: http://dbpedia.org/resource/Robert_Clarke_(academic)

Abstract is: Robert Clarke is a Northern Irish oncology researcher and academic administrator. He is the executive director of The Hormel Institute, a professor of biochemistry, Molecular Biology and Biophysics at the University of Minnesota, and ab Adjunct Professor of Oncology at Georgetown University. With his work focused in breast cancer research, Clarke studies how hormones (endogenous and exogenous) and related factors affect breast cancer. He has authored over 340 publications, and has 5 patents awarded. His research primarily focuses on determining an individual patient’s prognosis and the likelihood that they will respond to specific systemic therapies. His laboratory also studies drug resistance and the role of cell-cell communication in affecting dormancy and responsiveness to endocrine therapies breast cancers that express the estrogen receptor. Clarke is an elected Fellow of American Association for the Advancement of Science, the Royal Society of Chemistry, the Royal Society of Medicine, and the Royal Society of Biology. He is a Senior Editor for the journal Cancer Research.

Robert Clarke is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID010362102153.33
P227GND ID173880592
P2671Google Knowledge Graph ID/g/11rxrpbtn1
P1960Google Scholar author IDBgsjeHMAAAAJ
P269IdRef ID197636365
P6634LinkedIn personal profile IDrobert-clarke-phd-dsc
P2798Loop ID27488
P496ORCID iD0000-0002-9278-0854
P3829Publons author ID1541181
P1053ResearcherIDA-6485-2008
P2038ResearchGate profile IDRobert_Clarke2
P1153Scopus author ID56551716900
P214VIAF cluster ID328148704320536932257

P166award receivedFellow of the American Association for the Advancement of ScienceQ5442484
Fellow of the Royal Society of ChemistryQ5442487
Fellow of the Royal Society of MedicineQ59779997
P69educated atQueen's University BelfastQ877925
Ulster UniversityQ2096524
P108employerUniversity of MinnesotaQ238101
Georgetown UniversityQ333886
Georgetown University Medical CenterQ5547057
Georgetown University School of MedicineQ5547065
Hormel InstituteQ24061924
P734family nameClarkeQ1095787
ClarkeQ1095787
ClarkeQ1095787
P735given nameRobertQ4927937
RobertQ4927937
P106occupationresearcherQ1650915
oncologistQ16062369
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q31156840A ground truth based comparative study on clustering of gene expression data.
Q36566887A maternal diet high in n − 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring
Q35843483A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance.
Q33241980AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines
Q35057264AISAIC: a software suite for accurate identification of significant aberrations in cancers
Q81066714Acquired estrogen independence and antiestrogen resistance in breast cancer: estrogen receptor driven phenotypes?
Q41183303Acquisition of an antiestrogen-resistant phenotype in breast cancer: role of cellular and molecular mechanisms.
Q35689023Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation
Q41578634Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.
Q38406794Advancing Translational Research through Facility Design in Non-AMC Hospitals.
Q54751952Adverse interactions between cytotoxic drugs and hormonal agents in human breast cancer cells.
Q48445117Alterations in behavior, steroid hormones and natural killer cell activity in male transgenic TGF alpha mice
Q41639361Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells
Q41710247Animal models of breast cancer: experimental design and their use in nutrition and psychosocial research.
Q36713946Antiestrogen Resistance and the Application of Systems Biology
Q34272156Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.
Q28268250Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer
Q26866291Application of metabolomics in drug resistant breast cancer research
Q31147056Approaches to working in high-dimensional data spaces: gene expression microarrays
Q36213244Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer
Q38288109Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
Q100490944Author Correction: BICORN: An R package for integrative inference of de novo cis-regulatory modules
Q77725499Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients
Q27023375Autophagy and endocrine resistance in breast cancer
Q57814745Autophagy and unfolded protein response (UPR) regulate mammary gland involution by restraining apoptosis-driven irreversible changes
Q34518669Autophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cells
Q36039811BACOM2.0 facilitates absolute normalization and quantification of somatic copy number alterations in heterogeneous tumor
Q30855028BADGE: a novel Bayesian model for accurate abundance quantification and differential analysis of RNA-Seq data.
Q30432099BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.
Q94687270BICORN: An R package for integrative inference of de novo cis-regulatory modules
Q35671015BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency
Q35574312BMRF-Net: a software tool for identification of protein interaction subnetworks by a bagging Markov random field-based method.
Q30883476BSSV: Bayesian based somatic structural variation identification with whole genome DNA-seq data
Q39399977Biologically inspired survival analysis based on integrating gene expression as mediator with genomic variants.
Q44953213Biomarker identification by knowledge-driven multilevel ICA and motif analysis.
Q45061249Breast cancer cell obatoclax response characterization using passivated-electrode insulator-based dielectrophoresis
Q71878628Breast cancer risk in rats fed a diet high in n-6 polyunsaturated fatty acids during pregnancy
Q43849720C-7 analogues of progesterone as potent inhibitors of the P-glycoprotein efflux pump.
Q47216185CRNET: An efficient sampling approach to infer functional regulatory networks by integrating large-scale ChIP-seq and time-course RNA-seq data.
Q33967143Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland.
Q26995731Cannibalism, cell survival, and endocrine resistance in breast cancer
Q40190072Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity.
Q36817914ChIP-BIT: Bayesian inference of target genes using a novel joint probabilistic model of ChIP-seq profiles.
Q113309275ChIP-GSM: Inferring active transcription factor modules to predict functional regulatory elements
Q36950653Changes in mammary caveolin-1 signaling pathways are associated with breast cancer risk in rats exposed to estradiol in utero or during prepuberty
Q33523022Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis
Q40464259Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties.
Q34918110Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.
Q43513213Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase.
Q68117728Conformational and receptor binding properties of human EGF and TGF-alpha second loop fragments
Q33520897Cross phenotype normalization of microarray data
Q36259785CyNetSVM: A Cytoscape App for Cancer Biomarker Identification Using Network Constrained Support Vector Machines.
Q43125816DBC-1 mediates endocrine resistant breast cancer cell survival.
Q33812553DDN: a caBIG® analytical tool for differential network analysis
Q39402478DM-BLD: differential methylation detection using a hierarchical Bayesian model exploiting local dependency.
Q112618773Data-driven detection of subtype-specific differentially expressed genes
Q73614924Development of an immobilized P-glycoprotein stationary phase for on-line liquid chromatographic determination of drug-binding affinities
Q41669586Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status.
Q34565485Do estrogens always increase breast cancer risk?
Q34487539Dynamic Modeling of the Interaction Between Autophagy and Apoptosis in Mammalian Cells.
Q34192940Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells
Q47122770EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer.
Q54313198ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway.
Q70799119Early life affects the risk of developing breast cancer
Q36546451Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines
Q43947064Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells
Q69660043Effect of cytotoxic drugs on estrogen receptor expression and response to tamoxifen in MCF-7 cells
Q41350093Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts.
Q54216800Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies.
Q38747536Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
Q61818033Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model
Q36386322Endocrine resistance in breast cancer--An overview and update
Q40198514Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Q37072811Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer
Q35855031Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate.
Q68973307Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamole. The role of methotrexate polyglutamates
Q30405622Enhancing reproducibility in cancer drug screening: how do we move forward?
Q31074315Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures.
Q35634154Estrogen receptor-α signaling and localization regulates autophagy and unfolded protein response activation in ER+ breast cancer
Q91098603Estrogen-Induced Apoptosis in Breast Cancers Is Phenocopied by Blocking Dephosphorylation of Eukaryotic Initiation Factor 2 Alpha (eIF2α) Protein
Q40550409Expression of an estrogen receptor variant lacking exon 3 in derivatives of MCF-7 cells with acquired estrogen independence or tamoxifen resistance.
Q38318101Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays.
Q70675151Failure of 5-fluorouracil and methotrexate to destroy the reproductive integrity of a human breast cancer cell line (MCF-7) growing in vitro
Q45714359Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women.
Q27319225G-DOC Plus - an integrative bioinformatics platform for precision medicine.
Q35238047G-DOC: a systems medicine platform for personalized oncology
Q44972336GIST: a Gibbs sampler to identify intracellular signal transduction pathways
Q36759341GX15-070 (obatoclax) induces apoptosis and inhibits cathepsin D- and L-mediated autophagosomal lysis in antiestrogen-resistant breast cancer cells
Q35069549Gamma-tocotrienol induced apoptosis is associated with unfolded protein response in human breast cancer cells
Q33516560Gene module identification from microarray data using nonnegative independent component analysis
Q37401741Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells
Q35208950Gene selection for multiclass prediction by weighted Fisher criterion
Q37170530Gene signaling pathways mediating the opposite effects of prepubertal low-fat and high-fat n-3 polyunsaturated fatty acid diets on mammary cancer risk.
Q34354428Genome-wide identification of significant aberrations in cancer genome.
Q36622926Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness
Q92715598Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
Q47156376Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
Q78222414Growth and phenotypic characterization of porcine coronary artery smooth muscle cells
Q21996341Guidelines for the use and interpretation of assays for monitoring autophagy
Q36521680Heat shock 70 kDa protein 5/glucose-regulated protein 78 “AMP”ing up autophagy
Q35898237Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions
Q40607013Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.
Q41365153Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studies.
Q40877540Hormone resistance, invasiveness, and metastatic potential in breast cancer.
Q40101179Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines.
Q30417594Identification of condition-specific regulatory modules through multi-level motif and mRNA expression analysis.
Q73815854Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach
Q34047245Identifying cancer biomarkers by network-constrained support vector machines
Q36900433Identifying early events of gene expression in breast cancer with systems biology phylogenetics
Q36559266Identifying protein interaction subnetworks by a bagging Markov random field-based method.
Q36629870In Silico Discovery of Mitosis Regulation Networks Associated with Early Distant Metastases in Estrogen Receptor Positive Breast Cancers
Q68059385In vitro antineoplastic activity of C7-substituted mitomycin C analogues MC-77 and MC-62 against human breast-cancer cell lines
Q51903156Inferring network interactions using recurrent neural networks and swarm intelligence
Q28258801Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention
Q37234543Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement.
Q78115556Inhibition of estrogen receptor function promotes porcine coronary artery smooth muscle cell proliferation
Q67550875Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH
Q35142436Integration of Network Biology and Imaging to Study Cancer Phenotypes and Responses
Q45245687Interaction of dietary polyphenols with molecular signaling pathways of antiestrogen resistance: possible role in breast cancer recurrence.
Q35178371Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate
Q39221896Introduction: Cancer Gene Networks
Q41710325Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models.
Q30686050Iterative normalization of cDNA microarray data.
Q34880603KDDN: an open-source Cytoscape app for constructing differential dependency networks with significant rewiring
Q34038359Knowledge-fused differential dependency network models for detecting significant rewiring in biological networks
Q33547729Knowledge-guided gene ranking by coordinative component analysis
Q36023211LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines
Q44933111Latent variable and nICA modeling of pathway gene module composite.
Q47873418Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats
Q36836130Linking autophagy with inflammation through IRF1 signaling in ER+ breast cancer
Q42809219MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.
Q42815735MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen
Q36134468MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer.
Q34439115MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer
Q34504376Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring.
Q73404128Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring
Q48477249Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring.
Q36438365Mathematical modelling of transcriptional heterogeneity identifies novel markers and subpopulations in complex tissues
Q33656026Mathematical models of the transitions between endocrine therapy responsive and resistant states in breast cancer.
Q36326590Mechanisms mediating the effects of prepubertal (n-3) polyunsaturated fatty acid diet on breast cancer risk in rats.
Q55041780Meta-analysis of soy intake and breast cancer risk.
Q34367908Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells
Q37078095Module-based breast cancer classification
Q34668715Molecular mechanisms of tamoxifen-associated endometrial cancer (Review).
Q33584432Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER/PI3K/Akt/mTOR and IAP pathways
Q33322210Motif-directed network component analysis for regulatory network inference
Q41523907Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.
Q36345139Multidrug resistance/P-glycoprotein and breast cancer: review and meta-analysis
Q33857304Multilevel support vector regression analysis to identify condition-specific regulatory networks
Q34745409NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer
Q37938988NTP-CERHR expert panel report on the developmental toxicity of soy infant formula.
Q35991956Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.
Q35976826Opposing behavioural alterations in male and female transgenic TGF alpha mice: association with tumour susceptibility
Q31029221Optimized multilayer perceptrons for molecular classification and diagnosis using genomic data.
Q36455407Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.
Q48395472Overcoming cancer resistance.
Q37165163Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis
Q39360543PSSV: a novel pattern-based probabilistic approach for somatic structural variation identification.
Q40607026Perinatal factors increase breast cancer risk.
Q30441028Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.
Q61805769Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells
Q48438001Profile of Robert Clarke. Interviewed by Kristie Nybo, Ph.D.
Q33857080Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.
Q40100025Progressive loss of estrogen receptor alpha cofactor recruitment in endocrine resistance.
Q40661647Psychosocial factors in the development and progression of breast cancer.
Q47151773RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells.
Q90365558RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack
Q99727664Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer
Q33565567Reconstruction of gene regulatory modules in cancer cell cycle by multi-source data integration
Q36840512Reconstruction of transcriptional regulatory networks by stability-based network component analysis.
Q71230912Reduction of the anti-metabolic and anti-proliferative effects of methotrexate by 17 beta-oestradiol in a human breast carcinoma cell line, MDA-MB-436
Q68589706Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol
Q36009608Regulatory component analysis: A semi-blind extraction approach to infer gene regulatory networks with imperfect biological knowledge
Q41492304Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Q54108530Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
Q33481221Reverse engineering module networks by PSO-RNN hybrid modeling
Q57676341Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statistic
Q36143861Role of GRP78 in promoting therapeutic-resistant breast cancer
Q34603057Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α
Q50172986Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk.
Q42696647SparseIso: A novel Bayesian approach to identify alternatively spliced isoforms from RNA-seq data
Q41066361Steroid metabolism in the hormone dependent MCF-7 human breast carcinoma cell line and its two hormone resistant subpopulations MCF-7/LCC1 and MCF-7/LCC2.
Q92971911Systems biology: perspectives on multiscale modeling in research on endocrine-related cancers
Q28115071TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signaling
Q40133661The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines.
Q35684410The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer.
Q68939682The effect of leucovorin on the synthesis of methotrexate poly-gamma-glutamates in the MCF-7 human breast cancer cell line
Q43558847The effect of the rate of cell proliferation on the synthesis of methotrexate poly-gamma-glutamates in two human breast cancer cell lines.
Q52490490The effects of Mg2+ ions or EDTA on nuclear integrity and apparent subcellular distribution of unoccupied oestrogen receptors in breast cancer cells.
Q41306567The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.
Q43781864The enantioselective binding of mefloquine enantiomers to P-glycoprotein determined using an immobilized P-glycoprotein liquid chromatographic stationary phase.
Q42809581The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells.
Q72691580The kinetics of methotrexate polyglutamate formation and efflux in a human breast cancer cell line (MDA.MB.436): the effect of insulin
Q54299947The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity.
Q24815528The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells
Q40417107The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Q39713570The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival.
Q31140694The properties of high-dimensional data spaces: implications for exploring gene and protein expression data.
Q37553966The role of X-box binding protein-1 in tumorigenicity.
Q33555575The role of preclinical animal models in breast cancer drug development
Q69411578The unoccupied estrogen receptor: some comments on localization
Q30419997Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
Q77582009Timing of dietary fat exposure and mammary tumorigenesis: role of estrogen receptor and protein kinase C activity
Q74465247Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells
Q36006854Tyrosine-phosphorylated caveolin-1 (Tyr-14) increases sensitivity to paclitaxel by inhibiting BCL2 and BCLxL proteins via c-Jun N-terminal kinase (JNK).
Q34737311UNDO: a Bioconductor R package for unsupervised deconvolution of mixed gene expressions in tumor samples.
Q35763853Unfolding the Role of Stress Response Signaling in Endocrine Resistant Breast Cancers.
Q34473011Unsupervised deconvolution of dynamic imaging reveals intratumor vascular heterogeneity and repopulation dynamics
Q40984803Use of ERE and reporter gene constructs to assess putative estrogenic activity.
Q33827037VAV3 mediates resistance to breast cancer endocrine therapy.
Q35648915Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cells
Q35096599When is a vesicle not just a vesicle: mitochondrial spheroids and mitochondrial autophagosomes
Q33370429caBIG VISDA: modeling, visualization, and discovery for cluster analysis of genomic data
Q40550091interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
Q33640925mAPC-GibbsOS: an integrated approach for robust identification of gene regulatory networks.

The articles in Wikimedia projects and languages

      Robert Clarke (academic)wikipedia

Search more.